Seres Therapeutics Inc (MCRB) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Seres Therapeutics Inc   (NASDAQ: MCRB)


Seres Therapeutics Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Seres Therapeutics Inc's ROI in the second quarter of 2026?
Seres Therapeutics Inc recorded a cumulative net loss of $-22 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -21.41%.

Within the Healthcare sector 319 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 1818 to 3651.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM -8.4 % -19.28 % -27.38 % -43.94 % -54.39 %
Y / Y Net Income Change TTM - - -85.86 % -90.35 % -
Investment (TTM) in Millions 82 98 119 121 113
Return On Investment (TTM) -21.41 % -41.59 % 4.69 % 4.64 % 75.04 %
MCRB's Overall Ranking # 3651 # 1818 # 1390 # 60 # 88
Seq. Investment Change TTM -6.94 % -7.12 % 4.36 % 1.56 % -18 %
Seq. Net Income Change TTM - - 5.6 % -93.73 % 17.84 %
Net Income (TTM) in Millions -22 -47 6 5 86

MCRB Company Profile >> Back to MCRB Roi Comparisons >> See Annual MCRB Return On Investment



Return On Investment MCRB's Ranking
Within: No.
Industry # 116
Sector # 320
Overall # 3651

Return On Investment Statistics
High Average Low
75.04 %
-44.99 %
-119.81 %
(Jun 30 2025)   (Mar 31 2023)







Financial Statements
Seres Therapeutics Inc's II. Quarter Investments $ 82 Millions MCRB's Balance sheet
Seres Therapeutics Inc's II. Quarter Income $ 5 Millions Quarterly MCRB's Income Statement
MCRB's Income by Division See MCRB's Income by Division


MCRB Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 119 99 260 263 273
Y / Y Investment Growth 20.57 % -62.07 % -1.23 % -3.45 % -8.07 %
Net Income in Millions 6 0 -114 -250 -66
Y / Y Net Income Growth 4088.24 % - - - -
Annual Return On Investment 4.79 % 0.14 % -43.75 % -95.05 % -24.06 %


Annual Roi Comment
In the fiscal year 2025 ROI improved to 4.79 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
MCRB's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for MCRB's Competitors
Subscribers only: Roi for Seres Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for MCRB's Customers

Other Ratios
MCRB's Roa MCRB's Inventory Turnover Ratio MCRB's Growth Rates MCRB's Dividend Statistics
MCRB's Profitability Ratios MCRB's Asset Turnover Ratio MCRB's Dividend Growth
MCRB's Roe MCRB's Valuation Ratios MCRB's Financial Strength Ratios MCRB's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-10T16:17:22+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.